ZINACEF 250mg Price

Overview

Welcome to Dwaey, specifically on ZINACEF 250mg Injection/Powder for page.
This medicine contains an important and useful components, as it consists of Cefuroxime (as sodium).
ZINACEF 250mg is available in the market in concentration 250mg/Vial and in the form of Injection/Powder for.

GLAXOSMITHKLINE S.p.A. is the producer of ZINACEF 250mg and it is imported from ITALY, The most popular alternatives of ZINACEF 250mg are listed downward .

Mode Of Action

Cefuroxime binds to one or more of the penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death.

Indication

• Pharyngitis
• Acute otitis media
• Lyme disease
• Susceptible infections
• Sinusitis
• Otitis media
• Skin and skin structure infections
• Tonsillitis
• Respiratory tract infections
• Acute Maxillary Sinusitis
• Urinary tract infections
• Acute bacterial exacerbation of chronic bronchitis
• Surgical Prophylaxis

Precaution

Severe renal impairment; pregnancy, lactation; hypersensitivity to penicillins. Lactation: Drug excreted in breast milk; use with caution

Side Effects

• >10% Diarrhea (4-11%; depends on duration) 1-10% Decreased hemoglobin or hematocrit (10%)
• Eosinophilia (7%)
• Nausea or vomiting (3-7%)
• Vaginitis (<5%)
• Transient rise in hepatic transaminases (2-4%)
• Diaper rash (3%)
• Increase in alkaline phosphatase (2%)
• Thrombophlebitis (2%)
• Increase in lactate dehydrogenase (1%) <1% Anemia
• Cholestasis
• Colitis
• Dyspnea
• Epidermal necrolysis
• Increase in blood urea nitrogen (BUN) and creatinine
• Jaundice
• Nephritis
• Prolonged prothrombin time (PT)/international normalized ratio (INR)
• Rash
• Stevens-Johnson syndrome
• Stomach cramps
• Transient neutropenia and leukopenia
• Urticaria Potentially Fatal: Anaphylaxis
• nephrotoxicity
• pseudomembranous colitis.

Contra indication

Hypersensitivity to cephalosporins.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.